Digital Strategies for Recruitment to Improve Diversity and Inclusion in Prospective Cardiovascular Clinical Research [0.03%]
数字化策略在心血管临床研究招募中的应用以改善多样性及包容性
Sneha S Jain,Fatima Rodriguez,Marco V Perez et al.
Sneha S Jain et al.
Introduction: Cardiovascular trials often underrepresent non-White participants, women, and older individuals. Methods: We evaluated th...
Impact of Office and Ambulatory Blood Pressure on Mortality in Patients with Coronary Heart Disease [0.03%]
冠心病患者的办公室与门诊血压对死亡率的影响
Alejandro de la Sierra,Ernest Vinyoles,Manuel Gorostidi et al.
Alejandro de la Sierra et al.
Introduction: There is scarce evidence on the prognostic impact of ambulatory blood pressure monitoring (ABPM) in patients with coronary heart disease (CHD). We aimed to investigate the risks of all-cause and cardiovascul...
Treatment Patterns and Healthcare Resource Utilization Among Patients with Obstructive Hypertrophic Cardiomyopathy in Japan: A Claims Database Study [0.03%]
日本阻塞性肥厚性心肌病患者的治疗模式和医疗资源利用：基于索赔数据库的一项研究
Yuika Ikeda,Bruno Casaes Teixeira,Aman Malhi et al.
Yuika Ikeda et al.
Introduction: Obstructive hypertrophic cardiomyopathy (HCM) increases the risk of developing cardiac complications and can impact long-term outcomes, necessitating appropriate treatment. However, real-world data on how pa...
Hitting the Sweet Spot: A Review of SGLT2i in Cardiovascular Medicine [0.03%]
SGLT2i在心血管医学中的应用：全面回顾与展望
Zaid A Zayyad,Neil Gupta,Aanya Roy et al.
Zaid A Zayyad et al.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a class of medications initially developed for glycemic control in type 2 diabetes mellitus (T2DM) but found to have broader cardiometabolic impacts. In this review, we discuss the prop...
Resistant Blood Pressure: New Frontiers in Interventional Hypertension Therapy [0.03%]
难治性高血压：高血压介入治疗的新进展
Jeffrey D Taylor,Chukwunonyelum Uche,Vanessa Rowe et al.
Jeffrey D Taylor et al.
Hypertension remains a leading global health challenge, affecting over 1.3 billion individuals worldwide and contributing significantly to cardiovascular morbidity and mortality. In recent years, interventional device-based therapies have e...
Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study [0.03%]
Evolocumab治疗动脉粥样硬化性心血管病或杂合子型家族性高胆固醇血症的韩国患者：一项上市后监测研究
Donggyu Moon,Seung-Ho Hur,Sang-Rok Lee et al.
Donggyu Moon et al.
Introduction: The efficacy and safety of evolocumab have been established in clinical trials. This post-marketing surveillance (PMS) study investigated the real-world safety and effectiveness of evolocumab in patients wit...
Correction: Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Preliminary Cost-Effectiveness Analysis in the Italian Context [0.03%]
左心室辅助装置Impella与VA-ECMO在心脏源性休克患者中初步成本效益分析：意大利背景下的研究更正点评论
Carla Rognoni,Vittoria Ardito,Dario La Fauci et al.
Carla Rognoni et al.
Published Erratum
Cardiology and therapy. 2025 Sep 29. DOI:10.1007/s40119-025-00433-5 2025
Incomplete Right Bundle Branch Block: A Narrative Review of Clinical Relevance, Diagnostic Pitfalls, and Prognostic Implications [0.03%]
不完全右束支传导阻滞：临床意义、诊断陷阱及预后影响的叙述性回顾
Jozef Dodulík,Jiří Plášek,Jiří Vrtal et al.
Jozef Dodulík et al.
Introduction: Incomplete right bundle branch block (iRBBB) is a frequent electrocardiographic (ECG) finding, often considered benign. However, recent evidence suggests it may be associated with underlying structural or el...
Transthyretin Kinetic Stabilizers for ATTR Amyloidosis: A Narrative Review of Mechanisms and Therapeutic Benefits [0.03%]
转甲状腺素蛋白动力学稳定剂治疗ATTR淀粉样变性：机制和治疗效益的叙述性综述
Evan T Powers,Leslie Amass,Lori Baylor et al.
Evan T Powers et al.
Transthyretin amyloidosis (ATTR amyloidosis) is a systemic disease affecting multiple organ systems, particularly the heart and peripheral nervous system. Decades of research suggest the disease is caused by the dissociation, misfolding, an...
Jeffery W Kelly
Jeffery W Kelly